Concepedia

Tomoya Sameshima

TS

18

Publications

1.1K

Citations

17

H-Index

2008

Active since

Affiliations

Takeda (Japan)(Current)

Takeda (United States)

The University of Tokyo

National Institute of Health Sciences

Japan Science and Technology Agency

Tomoya Sameshima is an author at Takeda (Japan) specializing in medicine, natural sciences, and biochemistry.

ORCID

Top concepts

Publications per year

2008–2019

18

Publications

18

K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology

Kotaro Sakamoto, Yusuke Kamada, Tomoya Sameshima et al. · Biochemical and Biophysical Research Communications · 2017 · 110 citations

, , +9

Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins

Yuta Tanaka, Katsuji Aikawa, Goushi Nishida et al. · Journal of Medicinal Chemistry · 2013 · 108 citations · Full text

Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation

Nobumichi Ohoka, Yoko Morita, Katsunori Nagai et al. · Journal of Biological Chemistry · 2018 · 102 citations · Full text

Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein Degradation

Kenichiro Shimokawa, Norihito Shibata, Tomoya Sameshima et al. · ACS Medicinal Chemistry Letters · 2017 · 101 citations · Full text

Development of protein degradation inducers of oncogenic <scp>BCR</scp>‐<scp>ABL</scp> protein by conjugation of <scp>ABL</scp> kinase inhibitors and <scp>IAP</scp> ligands

Norihito Shibata, Naoki Miyamoto, Katsunori Nagai et al. · Cancer Science · 2017 · 98 citations · Full text

Rows per page

1–5 of 18